U.S. Machinery Stock News

PotlatchDeltic (PCH) delivered a sharp turnaround in profitability this quarter, with its net profit margin climbing to 5.8%, up from just 1.6% a year ago, and earnings rising 288.4% year-over-year. This is far stronger than its five-year average, which saw earnings declining 38.9% per year. Looking ahead, the company is forecasting annual earnings growth of 17.9%, set to outpace the broader US market, while management values shares below their estimated fair value at $38.95. These improving...

Federal Agricultural Mortgage (AGM) posted net profit margins of 50.9%, edging up from last year’s 49%. Over the past five years, AGM has averaged 14.2% annual earnings growth, and most recently, earnings climbed 13.1%. Looking ahead, earnings are projected to rise about 8% per year, a pace that trails the wider US market's expected 16% annual growth. Revenue growth is anticipated to slightly outperform at 10.8% per year compared to the US market’s 10.5%. See our full analysis for Federal...

Super Group (SGHC) posted a striking surge in net profit margins, coming in at 9.8% compared to just 0.3% last year. This improvement was fueled by an extraordinary 4,994.9% earnings growth over the same period. Looking ahead, the company’s earnings are expected to grow 32.2% per year, far outpacing the broader US market’s forecast of 16% per year. Revenue is projected to rise by 9.2% annually, just below the US average of 10.5%. With these numbers, investors are seeing a notable turnaround...

Vornado Realty Trust (VNO) has turned profitable, posting a robust 46.1% per year earnings growth rate over the last five years, but recent results were boosted by a one-off gain of $827.3 million. Although net profit margins have moved into positive territory, forecasts now call for earnings to drop sharply by 83.8% per year over the coming three years. Revenue is projected to rise at a slower 3.3% per year, which is behind the broader US market’s 10.5% per year expectation. With profits...

Ever wondered if Alight could be a hidden gem or is already priced to perfection? If you’re on the hunt for value, you might be surprised by what the numbers reveal. It's been a rollercoaster for Alight’s shareholders. They have seen the stock drop 12.3% in the last week and a staggering 60.0% since the start of the year, signaling a big shift in how the market values the business. Recently, Alight made headlines by entering new partnerships that aim to strengthen its position in the...

CytomX Therapeutics announced it will present initial translational data from its ongoing Phase 1 study of CX-801 in advanced melanoma at the Society for Immunotherapy of Cancer (SITC) 40th Anniversary Annual Meeting, scheduled for November 7-9, 2025, in National Harbor, MD. This upcoming clinical update provides stakeholders with a key opportunity to assess the potential of CytomX's immunotherapy pipeline, possibly shaping future expectations around its development progress and clinical...

Sealed Air Corporation recently reported third-quarter 2025 earnings, highlighting a substantial increase in net income to US$255.1 million and diluted earnings per share to US$1.73, compared to the same period last year, with sales remaining largely unchanged at US$1.35 billion. This performance suggests operational efficiencies are compensating for flat revenue, as the company also reaffirmed its full-year earnings guidance despite continued volume pressures in several segments. We’ll...

Curious if Hertz Global Holdings is a bargain or a bounce trap? You're not alone, and we're diving deep to see just how much value might be hiding in the numbers. The stock has rocketed up 32.4% year to date and gained an impressive 69.8% over the past year, even though it has dipped 4.4% in the last week and 21.0% over the past month. Momentum has largely been sparked by renewed attention on the used car market and shifting consumer travel habits, both of which put Hertz in the spotlight...

Heritage Insurance Holdings Inc will report its Q3 2025 earnings on November 5, 2025, following a quarter where its actual earnings per share significantly surpassed analyst expectations even as revenue came in below estimates. This divergence between stronger-than-expected earnings and softer revenue projections, alongside upward earnings estimate revisions and declining revenue forecasts for 2025 and 2026, has driven increased investor attention ahead of the upcoming results. We will...

Marathon Petroleum Corporation's ( NYSE:MPC ) periodic dividend will be increasing on the 10th of December to $1.00...

Pfizer Inc. ( NYSE:PFE ) stock is about to trade ex-dividend in 2 days. The ex-dividend date is one business day before...

The Plug Power Inc. ( NASDAQ:PLUG ) share price has softened a substantial 28% over the previous 30 days, handing back...

Twilio Inc. ( NYSE:TWLO ) shares have had a really impressive month, gaining 32% after a shaky period beforehand...

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Ideally, a...

Some stocks are best avoided. It hits us in the gut when we see fellow investors suffer a loss. Spare a thought for...

In the current U.S. market landscape, major stock indexes have experienced a pullback, with tech shares leading the decline despite some companies posting strong quarterly results. Amidst this backdrop of fluctuating indices and economic uncertainty, identifying growth companies with high insider ownership can be crucial for investors seeking potential resilience and alignment of interests between management and shareholders.

Rani Therapeutics Holdings announced it would present preclinical data on its RaniPill® oral delivery platform at ObesityWeek® 2025, highlighting that oral semaglutide (RT-116) in dogs is bioequivalent to subcutaneous injections and produces similar weight loss. This research could generate interest, as it demonstrates the potential for the RaniPill to enable oral delivery of peptide drugs traditionally administered via injection. We'll examine how these promising preclinical results for...

Pacific Biosciences of California (PACB) shares jumped after news broke that ARK Investment Management, led by Cathie Wood, had acquired over one million shares. This high-profile buy is increasing investor attention and speculation around PacBio’s DNA sequencing technology and its growth outlook. See our latest analysis for Pacific Biosciences of California. ARK’s sizeable buy-in comes as PacBio’s share price has staged a sharp reversal. After months of drifting, the past 30 days saw a...

We feel now is a pretty good time to analyse Blend Labs, Inc.'s ( NYSE:BLND ) business as it appears the company may be...

Stepan Company's ( NYSE:SCL ) periodic dividend will be increasing on the 15th of December to $0.395, with investors...

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...

If you are building a properly diversified stock portfolio, the chances are some of your picks will perform badly. But...

As the U.S. market navigates a mixed landscape with the Dow faltering and Nasdaq gaining momentum, investors are keenly observing how tech giants' cloud computing deals and AI investments are influencing broader market sentiment. In this context, identifying high-growth tech stocks often involves looking for companies that are effectively capitalizing on emerging technologies and strategic partnerships to drive innovation and revenue growth.

As the U.S. stock market experiences mixed performances, with tech stocks showing resilience amid a backdrop of economic uncertainty, investors are increasingly exploring diverse opportunities. Penny stocks, often associated with smaller or newer companies, continue to attract attention for their potential to uncover hidden value despite being considered a niche investment area today. By focusing on those backed by strong financials and promising growth prospects, investors can find...